Fred R. Volkmar, M.D., is the Irving B. Harris Professor of Child Psychiatry, Pediatrics, and Psychology at Yale University, and Director of the Yale Child Study Center. He also serves as Chief of Child Psychiatry at Yale-New Haven Hospital. His academic affiliations include the Yale School of Medicine and leadership roles in multiple clinical and research programs. Dr. Volkmar holds an M.D. from Stanford University (1976) and a psychology master’s degree from the same institution, alongside an undergraduate psychology degree from the University of Illinois (1972). He is renowned for authoring the DSM-IV autism and pervasive developmental disorders section and has authored hundreds of publications and several influential books, including Asperger’s Syndrome and Handbook of Autism . His research focuses on autism spectrum disorders (ASD), including diagnosis, treatment, comorbidities, and transition to adulthood. His publications emphasize evidence-based practices, neurodevelopmental mechanisms, and clinical guidelines. He leads initiatives in medical care for ASD populations and advocates for improved community support systems. Notable contributions include co-developing the M-CHAT screening tool and advancing interdisciplinary approaches to ASD management. His work intersects clinical practice, policy, and education, prioritizing patient-centered care and reducing stigma.
Paul-Christian Burkner is a researcher in the Department of Computer Science at Aalto University. His work focuses on Bayesian statistical methods, computational modeling, and probabilistic programming. He collaborates with Professor Aki Vehtari's research group and has published extensively on topics like model sensitivity, spatiotemporal analysis, and variable selection techniques. His research interests include: Bayesian inference and model comparison Computational statistics Probabilistic programming Machine learning algorithms Statistical modeling in social sciences Neuroimaging data analysis Recent publications demonstrate expertise in simulation-based calibration, spatiotemporal modeling, and Gaussian process approximations. Collaborations span psychology, neuroscience, and machine learning domains. Contact: ext-paul-christian.burkner@aalto.fi
Prof. Dr. Silvia Schneider is a distinguished Professor of Clinical Child and Adolescent Psychology at Ruhr University Bochum, where she serves as Director of the Research and Treatment Center for Mental Health (FBZ). She also coordinates the Bochum-Marburg site of the German Center for Mental Health (DZPG). Previously, she held professorial positions at the University of Basel, where she served as Dean of the Psychology Faculty. Her academic career spans over three decades with significant contributions to child and adolescent mental health research. Dr. Schneider earned her doctorate from Philipps-University Marburg in 1992 with highest honors (summa cum laude) for her dissertation on "Psychological Transmission of Panic Syndrome." She completed her habilitation at Technical University Braunschweig in 2002. Her academic qualifications include board certification as a Psychological Psychotherapist (1999) and specialized credentials in behavioral therapy for children and adolescents (1998). Dr. Schneider's research primarily focuses on the etiology, prevention, and treatment of emotional disorders in childhood and adolescence. Her work examines familial transmission of emotional disorders, clinical baby and infant research, and diagnosis of mental disorders across the lifespan. She has pioneered research on anxiety disorders, particularly separation anxiety, and has developed innovative treatment approaches including exposure-based therapies. Her current work increasingly integrates neurobiological perspectives with clinical interventions, examining brain-behavior relationships in anxiety disorders through neuroimaging studies. Her extensive publication record demonstrates a consistent focus on child and adolescent mental health, with recent work expanding into digital interventions, virtual reality therapies, and large-scale multicenter studies examining anxiety disorders from both clinical and neurobiological perspectives. Her research bridges basic science with clinical application, maintaining a strong focus on evidence-based interventions for children and families. Visiting Professor at Anxiety and Depression Research Center, UCLA (2015-2016) Visiting Scholar at Center for the Treatment and Study of Anxiety, University of Pennsylvania (2009-2010) Honorary Professorship at University of Surrey Roehampton (2003-2010) Swiss National Science Foundation Professorship (2003-2006) DFG Habilitation Scholarship (1998-2001) Cassianeum Educational Foundation Dissertation Prize (1994) Dr. Schneider has successfully secured substantial research funding from major German and international funding bodies including the German Research Foundation (DFG), German Federal Ministry of Education and Research (BMBF), and Swiss National Science Foundation. Her current projects include "The Role of Parents in Child Development in the Context of Immigration" (DFG), "Mobile Research Laboratory" (DFG), and "Improving Mental Health in Refugee Families" (BMBF). As Director of the FBZ, she leads a large interdisciplinary team conducting cutting-edge research while providing evidence-based clinical services. As Director of the Research and Treatment Center for Mental Health (FBZ) at Ruhr University Bochum, Dr. Schneider oversees a comprehensive research infrastructure supporting studies from basic developmental science to clinical interventions. The FBZ serves as a hub for interdisciplinary collaboration across psychology, psychiatry, and neuroscience, with particular strengths in anxiety disorders research, early intervention, and innovative treatment approaches including digital health solutions.
Karestan C. Koenen is Professor of Psychiatric Epidemiology at the Harvard T.H. Chan School of Public Health and an Associate Member at the Broad Institute of MIT and Harvard . She also serves as Affiliated Faculty at the Harvard University Center for the Environment , advising students in Epidemiology and Social Behavioral Sciences. BA in Economics, Wellesley College MA in Developmental Psychology, Columbia University PhD in Clinical Psychology, Boston University Post-doctoral Fellowship in Psychiatric Epidemiology, Columbia University Dr. Koenen's research focuses on three areas: (1) understanding PTSD resilience, (2) trauma's long-term physical health impacts, and (3) expanding access to evidence-based mental health treatments. Her work bridges genetics, global mental health, and trauma epidemiology, with recent studies on epigenetic aging, cognitive outcomes after trauma, and substance use comorbidities. Her 2025 publications span psychiatric genetics, trauma neurobiology, and women's health, emphasizing machine learning, neuroimaging, and population-level interventions. Current projects include the Broad Trauma Initiative and NIMH-funded training programs. 2025 Junior Faculty Mentoring Award 2021 Pamela Sklar Innovation Award 2017 Distinguished Alumnae Award 2015 Robert S. Laufer Memorial Award Dr. Koenen actively trains graduate students through the Trauma Epidemiology and Population Mental Health Research Group . She integrates advocacy into her work, having testified before Congress and consulted on documentaries about trauma, while publishing in outlets like the Boston Globe and Psychology Today . Her lab collaborates on mental health policy and global trauma research.
Caroline Samer is an Associate Professor at the University of Geneva (UNIGE) Faculty of Medicine and serves as the Head of the Division of Clinical Pharmacology and Toxicology at the Hôpitaux Universitaires de Genève (HUG) . She also acts as the Delegate to the Dean's Office for Data Issues since July 2023. Medical Degree (2001), PhD in Pharmacogenomics, Postdoctoral Fellowship in Molecular Pharmacology (Sydney) President of the Swiss Society for Clinical Pharmacology and Toxicology (SSPTC) and Swiss Society of Pharmacology and Toxicology (SSPT) Vice-President of Swissethics and the Geneva Research Ethics Committee (CCER) Her research focuses on personalizing drug therapy through pharmacogenomics and precision medicine , emphasizing gene-environment-disease interactions and omic technologies . Key themes include drug interactions , pharmacokinetic modeling , and therapeutic information . Recent publications highlight her work in pharmacogenomics , drug safety , and clinical pharmacology , with a focus on opioids , antiaggregants , and drug metabolism . Her collaborations span oncopediatrics , internal medicine , medical informatics , and pharmaceutical sciences . She leads the Samer-Daali Research Group , which integrates in vitro , in vivo , and in silico models to advance personalized therapy . Her work is supported by institutional affiliations with the Faculty Center of Translational Investigation in Biomarkers and CIOMS .
Amanda Jensen-Doss is a Professor and Director of Clinical Training in the Department of Psychology at the University of Miami's College of Arts and Sciences. Her work focuses on improving mental health care for children and adolescents through evidence-based practices, particularly in community settings. She leads the Child Implementation and Effectiveness Lab (CIELO Lab), which emphasizes translating research into clinical practice. Her research interests include measurement-based care (MBC), trauma-informed treatments, and implementation science. She has extensively studied clinician training, consultation strategies, and the role of data in optimizing youth psychotherapy outcomes. Key areas of focus include unaccompanied migrant children, adolescent treatment engagement, and therapist fidelity to evidence-based protocols. Dr. Jensen-Doss collaborates with community agencies to scale up evidence-based practices (EBPs), addressing barriers like funding and clinician self-efficacy. Her work bridges academic research with real-world clinical challenges, emphasizing pragmatic solutions to enhance mental health service delivery. She has contributed to national initiatives on MBC and EBP sustainability, and her lab provides resources for clinicians via platforms like shinyDLRs diagnostic tool. Notable grants and projects include the COMET study (Community Study of Outcome Monitoring for Emotional Disorders in Teens), which evaluates transdiagnostic treatments, and a focus on modular therapy approaches for anxiety, trauma, and conduct problems in schools. She advocates for clinician training models that balance expert consultation with cost-effectiveness. Her lab’s CIELO Lab website highlights ongoing projects on family support protocols for internalizing disorders and podcasts to improve health literacy. She is active in editorial roles, emphasizing methodological rigor and translational research in youth mental health.
Anne Holland is Professor of Physiotherapy and Head of Respiratory Research at Monash University and Alfred Health in Melbourne, Australia. She is an NHMRC Leadership Fellow (2021–2025) and a Chief Investigator for the NHMRC Centre of Research Excellence in Pulmonary Fibrosis and the NHMRC Centre of Research Excellence in Treatable Traits. Her research focuses on supportive therapies for chronic respiratory diseases, particularly COPD and pulmonary fibrosis, with a strong emphasis on pulmonary rehabilitation, telerehabilitation, and ambulatory oxygen therapy. Her research interests include: Respiratory physiotherapy Pulmonary rehabilitation (home-based and low-cost models) Access to care for chronic lung disease Telerehabilitation and digital health Symptom management in interstitial lung disease Exercise training and physical activity promotion Her recent publications focus on symptom management, digital self-management tools, treatable traits models, and clinical trials in pulmonary fibrosis and COPD. The body of work reflects a strong trend toward patient-centered, accessible, and evidence-based interventions that improve quality of life and clinical outcomes in chronic respiratory conditions. Her major scientific awards include: Society Medal, Thoracic Society of Australia and New Zealand (2021) European Respiratory Society Gold Medal for Allied Health Professionals (2022) NHMRC Investigator Fellow (Leadership 1) (2021) Fellow, Thoracic Society of Australia and New Zealand (2019) American Thoracic Society Pulmonary Rehabilitation Assembly Award (2016) Anne Holland supervises PhD students and is actively involved in advising and grant leadership. She is the Primary Chief Investigator on major trials such as the PERFORM trial and the TAPPET trial, and she leads a multinational ambulatory oxygen trial for fibrotic lung disease. Her work is supported by NHMRC and international collaborations. She is also President of the Thoracic Society of Australia and New Zealand, reflecting her leadership in the field. Anne leads the Holland Respiratory Care Research Group at Monash, which focuses on innovative models of care delivery, validation of remote monitoring tools, and improving patient self-management in chronic lung disease. The team collaborates widely across Australia and internationally, particularly in trials involving pulmonary rehabilitation and treatable traits.
Francesco Maisano, MD , is Full Professor of Cardiac Surgery at Vita-Salute San Raffaele University (Milan) since 2021, where he also serves as Director of the Cardiac Surgery Clinic and of the Valve Center at IRCCS San Raffaele Hospital. From 2014 to 2020 he held the Chair of Cardiac Surgery and directed the Department at University Hospital Zurich. Education & Training 1990 – MD, Catholic University of Rome 1994 – Clinical Fellowship, University of Alabama at Birmingham 1995 – Specialization in Cardiac Surgery, La Sapienza University of Rome Research Interests Professor Maisano’s work centres on innovative therapies for heart-valve disease, spanning surgical reconstruction, catheter-based interventions (TAVI, MitraClip, transcatheter tricuspid devices), and hybrid approaches. He leads translational programmes in biomedical engineering, multimodality cardiac imaging, and artificial-intelligence-guided interventions, with emphasis on the multidisciplinary “Heart Team” model for complex cardiovascular disease. His recent publications (2024-2025) demonstrate intense activity in transcatheter mitral and tricuspid repair, long-term durability of surgical mitral repair, AI-driven procedural guidance, and renal protection strategies during mechanical circulatory support. A dominant theme is translating imaging innovations and device concepts into first-in-human studies and large-scale registries. Scientific Awards & Recognitions European Society of Cardiology Silver Medal (2018) ICI Lifetime Achievement in Research & Teaching (2018) ICI Best Technology Parade Presentation (2010) C. Walton Lillehei Young Investigator Award (1999) Leadership & Grants He directs multiple postgraduate programmes, including Certificate of Advanced Studies (CAS) tracks at the University of Zurich in multimodality imaging, aortic valve, and mitral–tricuspid interventions. He is principal investigator on investigator-initiated grants, coordinates industry-partnered device trials, and mentors numerous doctoral and post-doctoral researchers. His team has filed >24 patents and spun off several cardiovascular start-ups. Labs & Teams At IRCCS San Raffaele he leads the Valve Science Center , a multidisciplinary hub integrating cardiac surgeons, interventional cardiologists, imaging specialists, biomedical engineers, and data scientists focused on next-generation valve repair/replacement technologies and personalised cardiovascular medicine.
Dr. Ed E. Moret is an Associate Professor of Computational Medicinal Chemistry at Utrecht University, where he serves as Managing Director of the Utrecht Institute for Pharmaceutical Sciences. He is a member of the Departmental Executive Board and Chair of the Board of Examiners of the School of Pharmacy. His academic career spans over three decades with significant contributions to pharmaceutical sciences. Utrecht University, Utrecht Institute for Pharmaceutical Sciences School of Pharmacy, Department of Chemical Biology and Drug Discovery Managing Director since January 2010 Dr. Moret's educational background includes completing Gymnasium-b at Gymnasium Camphusianum in Gorinchem in 1979, followed by pharmacy studies at Utrecht University until 1988. He earned his PhD in 1993 with research on calculations and simulations of DNA-alkylating cytostatics under supervision of Prof. L.H.M. Janssen and Prof. J.P.A.E. Tollenaere. He also conducted postdoctoral research at the Scripps Research Institute with Prof. A.J. Olson. His primary research interests focus on molecular recognition, particularly in auto-immune diseases, with expertise spanning computational medicinal chemistry, computer-aided drug discovery, cheminformatics, and bioinformatics. Dr. Moret's work bridges the gap between theoretical calculations and experimental validation in drug design. His research portfolio demonstrates a consistent trajectory from fundamental molecular interactions to applied drug discovery, with particular emphasis on enzyme inhibitors, carbohydrate-protein interactions, and molecular recognition processes. Analysis of his publication record reveals a strong focus on structure-based drug design, with significant contributions to the development of inhibitors for enzymes like β-glucocerebrosidase, NNMT, and neuraminidase. His work spans multiple therapeutic areas including lysosomal storage disorders, cancer metabolism, and infectious diseases. The interdisciplinary nature of his research is evident in the integration of computational approaches with experimental validation across biochemistry, pharmacology, and medicinal chemistry. Teacher of the Year (awarded three times by Pharmacy students) Member of editorial boards for Medicines and Conceptuur journals Secretary of Board of FIGON (2016) Secretary of Raad voor de Farmaceutische Wetenschappen (2024) Member of Board of Stichting Farmaceutische Erfgoed (2024) Dr. Moret has been actively involved in educational innovation, developing and coordinating the master's programme Drug Innovation, the profile Drug Regulatory Sciences, and the Honours programme Pharmaceutical Sciences. He has taught courses for pharmacy, chemistry, UCU and medical sciences students, as well as PhD courses in bioinformatics and computer-aided drug discovery. His educational contributions include developing an inquiry-based elective course on drug discovery, for which he published educational research. He holds BKO and SKO teaching qualifications and participated in the Centre of Excellence in University Teaching program. As Managing Director of the Utrecht Institute for Pharmaceutical Sciences, Dr. Moret leads research initiatives across chemical biology, drug discovery, and pharmaceutical sciences. His leadership extends to multiple advisory and editorial roles within the pharmaceutical research community, reflecting his significant contributions to both academic and professional spheres of pharmaceutical sciences.
Dr. Alexandre Marques is an Assistant Professor at the University of Southern Mississippi. His expertise spans Microbiology, Immunology, and Parasitology, with a focus on vaccine development against parasitic infections like Leishmaniasis, Chagas disease, and Malaria. He holds a PhD from the Universidade de São Paulo (2007) and teaches courses such as Gen Microbiology and Microorg Hth Di at the university. His research integrates immunological, clinical, and molecular approaches to understand parasitic disease mechanisms and therapeutic interventions. Notable areas include α-Gal immunization strategies, transcriptomic analysis of breast cancer, and vaccine design against Leishmania. He has also explored applications in aquaculture nutrition and cosmetic safety assessments. Dr. Marques’ work spans interdisciplinary collaborations, including veterinary medicine, nanotechnology-based drug delivery, and antimicrobial stewardship in pediatrics. His contributions to animal models for Chagas disease and canine visceral leishmaniasis highlight translational research impact. Key themes in his publications include immune response modulation, pathogen-host interactions, and biomarker discovery in chronic infections. He has published over 50 articles across microbiology, immunology, and biomedical engineering since 2007.
Debbie Senesky is an Associate Professor at Stanford University in both the Aeronautics and Astronautics Department and the Electrical Engineering Department, as well as a Senior Fellow at the Precourt Institute for Energy. She serves as the Principal Investigator of the EXtreme Environment Microsystems Laboratory (XLab) and Site Director of nano@stanford. Dr. Senesky received her B.S. in mechanical engineering from the University of Southern California (2001), followed by M.S. (2004) and Ph.D. (2007) degrees in mechanical engineering from the University of California, Berkeley. Prior to joining Stanford, she held positions at GE Sensing (formerly NovaSensor), GE Global Research Center, and Hewlett Packard. Her research focuses on developing nanomaterials and electronic systems capable of operating in extreme environments, including high-temperature conditions for Venus exploration, microgravity synthesis of nanomaterials, and harsh environment electronics. Dr. Senesky's work bridges multiple disciplines, connecting aerospace engineering, electrical engineering, materials science, and space technology to solve challenges in extreme environment applications. Dr. Senesky has made significant contributions to the field of high-temperature electronics, GaN-based sensors, graphene aerogel synthesis in microgravity, and materials for space applications. Her recent publications demonstrate a strong focus on practical applications of these technologies, particularly for space exploration and extreme environment sensing. Presidential Early Career Award for Scientists and Engineers (PECASE), NASA (2025) Emerging Leader Abie Award from AnitaB.org (2018) Early Faculty Career Award from NASA (2012) Gabilan Faculty Fellowship Award (2012) Sloan Ph.D. Fellowship (2004-2006) Dr. Senesky actively advises students at all levels, from undergraduate to postdoctoral researchers, and has established herself as a leader in promoting diversity in STEM through her role as Faculty Advisor for the Stanford Chapter of the National Society of Women Engineers. Her collaborative approach is evident in her numerous interdisciplinary projects and partnerships with NASA, industry, and other research institutions. She directs the EXtreme Environment Microsystems Laboratory (XLab), which focuses on developing technologies for operation in extreme environments including high temperature, radiation, and microgravity conditions. The lab's work has applications for space exploration, particularly for Venus missions, as well as terrestrial applications requiring robust electronics.
Gavin Schwarz is a Professor and Head of School at the School of Management and Governance within the UNSW Business School . He specializes in organizational change , organizational failure and inertia , and the dynamics of virtual teams , with a focus on how organizations fail during change processes and how to develop applied strategies for change management . His work spans diverse sectors including healthcare, technology, and education, with publications in leading journals such as Academy of Management Learning and Education and Administrative Science Quarterly . Education : PhD in Management (University of Queensland), MPhil (Hons) in Management (University of Auckland), BA in Management and English (University of Auckland). Grants : 2020 Brock University grant for "University communication in times of COVID-19" , 2020 UNSW Medicine grant for "Translation and change: Embedding effective change management in health" , and earlier Australian Research Council and Gordon J. Samuels Fellowship awards. His research explores the development of knowledge in organizational theories , with an emphasis on collective responses to change , HR management during crises , and technology strategy . He has contributed to understanding organizational communication , team innovation , and structural inertia . His 15 most recent publications cover topics from AI’s role in organizational change to pandemic-driven research adaptation, with keywords spanning management science , behavioral economics , and digital transformation . Scientific Awards 2021-2023 : Outstanding Reviewer Awards (Academy of Management Review) 2017-2020 : Best Reviewer Awards (Journal of Organizational Behavior) 2019, 2013, 2011 : Best Paper Finalist/Awardee (Academy of Management divisions) 2007, 2006 : Editorial Board Excellence (Academy of Management Journal) and Gordon J. Samuels Fellowship As an active supervisor in organizational change and HR development , his work supports healthcare innovation and digital transformation. He serves as Editor-in-Chief for the Journal of Applied Behavioral Science and is on the editorial boards of Academy of Management Review , Journal of Management , and Journal of Organizational Behavior . Contact: g.schwarz@unsw.edu.au
Prof. Zena Moore is a renowned academic and clinician serving as Professor and Head of the School of Nursing & Midwifery at RCSI, University of Medicine and Health Sciences. She holds adjunct professorships at Curtin University (Australia), Griffith University (Australia), Cardiff University (UK), Ghent University (Belgium), and Fakeeh College for Medical Sciences (Saudi Arabia). Her research focuses on wound healing, pressure ulcer prevention, and nursing education, with over 300 publications. She leads the Skin Wounds and Trauma (SWaT) Research Centre and chairs multiple international bodies including the European Pressure Ulcer Advisory Panel. Education: PhD in Wound Healing (RCSI), MSc in Leadership in Health Education (RCSI), MSc in Wound Healing (University of Wales), FFNMRCSI, and Diplomas in Management and Nursing. Research Interests: Wound pathophysiology, pressure ulcer risk assessment, technologies for early detection, and healthcare equity. Awards: 2022 Lifetime Achievement Award from World Union of Wound Healing Societies. Her work spans over 50 funded projects, including grants from Science Foundation Ireland and the National Health and Medical Research Council. She has supervised numerous research projects on topics like pressure ulcer prevention algorithms and eHealth interventions.
Martha C. Tompson is Associate Professor and Clinical Program Director in the Department of Psychological & Brain Sciences at Boston University. She earned her PhD from UCLA and directs the Family Development and Treatment Lab. Her research examines family processes in mental health, with focus on depression, bipolar disorder, and schizophrenia interventions. Key research areas include: Family-focused treatments for childhood depression Impact of maternal depression on child development Family psychoeducation for bipolar disorder Dr. Tompson has developed novel family-based interventions for preadolescent depression and studied transgenerational transmission of depression vulnerability. Her work emphasizes culturally responsive treatments and includes randomized trials demonstrating treatment efficacy. She mentors clinical psychology students and teaches evidence-based intervention strategies.
Amy Vaughan Van Hecke serves as Assistant Chair and Professor in Marquette University's Department of Psychology, leading research on autism spectrum disorder (ASD) and social development across the lifespan using neuroimaging and psychophysiological methods. She directs community initiatives to improve autism services access for underserved Milwaukee populations through the Next Step Clinic. Her academic foundation includes: B.A. in Psychology from Smith College Ph.D. in Developmental Psychology from the University of Miami Dr. Van Hecke's research centers on brain activity, heart rate regulation, and social behavior in individuals with and without ASD, utilizing high-density EEG and MRI to examine neural responses to interventions like PEERS ® . Current projects investigate pandemic impacts on social interaction in autistic adults and neural mechanisms of social isolation remediation. Her work bridges laboratory neuroscience with community-based clinical applications. Publication analysis reveals consistent focus on intervention efficacy (particularly PEERS ® ), neural plasticity measurement, and comorbid conditions across developmental stages. Recent work emphasizes gender-specific outcomes, family impacts, and pandemic-related mental health, demonstrating methodological diversity from EEG asymmetry to community-based participatory research. Her distinguished scientific recognition includes: Kirschstein National Research Service Award (NRSA) from the National Institute of Mental Health Dr. Van Hecke mentors students through her Marquette Autism Project lab and the Next Step Clinic training program while securing major grants from Marquette University, Johnson Controls Foundation, and the Greater Milwaukee Funders’ Collaborative. She teaches undergraduate/graduate courses in developmental psychology and statistics. Advising: Clinical psychology graduate mentorship (excluding 2025 intake); undergraduate research supervision Grants: $500k+ secured for Next Step Clinic serving underserved Milwaukee children She co-directs the Marquette Interdisciplinary Autism Initiative and the Next Step Clinic, which employs a Family Navigation model in Milwaukee's Metcalfe Park neighborhood to provide autism screening, diagnosis, and therapy for children aged 15 months-10 years facing systemic barriers to care.
